Wednesday 23 January 2019 | ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares
Eagle Eye Solutions – “delighted” on H1 & growth expected to continue into H2… but what about that cash burn?
I told you that Metro Bank was dodgy...and that you shouldn't underestimate Burberry's Chinese chavs!
Previously writing, in November, as shares in InnovaDerma (IDP) fell towards 100p, I concluded that there looked good reason for scepticism – with the company still needing to show delivery to suggest current year revenue and also, of course, bottom-line forecasts are achievable. Now a “Trading Statement” – and the shares down approaching 16%, below 80p, in response…
“UK developer of life sciences, beauty and personal care products”, InnovaDerma (IDP) has made an AGM update including “our distribution channels will increase significantly this financial year as our UK retail store network grows from c.800 (FY2017) to c.2,400”. So why a current 15% share price fall, towards 100p?...
I first warned on shares in InnovaDerma (IDP) in January as they fell towards 230p. Less than two months later it was a profit warning, though the shares are currently bouncing more than 25% higher today, towards 140p – a market cap of circa £20 million, on the back of an “Appointment of CEO and Roots to be ranged in Tesco” announcement…
Life sciences, beauty and personal care products company InnovaDerma (IDP) has updated on trading for its year ending 30th June – commencing “revenue for the period increased strongly by 23.5% on a constant currency basis to approximately £11m (FY2017: £8.9m). However,”, Uh oh…
Whenever a company doubles in share price in a short space of time it tends to get my attention, and I look for reasons that justify such a sudden increase.
Writing on InnovaDerma (IDP) in January with the shares towards 230p, I concluded at least ahead of further comfort of the second half weighting expected actually being delivered, I avoid. Now a 10:13 “Trading Statement”. Uh oh…
InnovaDerma (IDP) “is pleased to provide a trading update for the six months ended 31 December 2017” - and it includes “the board remains confident in meeting market expectations for the current financial year and has much greater revenue visibility for the second half than in prior years”. So why an approaching 13% share price fall on the back of it, towards 230p?...
Search ShareProphets |
Recent Comments |